Format

Send to

Choose Destination
Small. 2018 Jan;14(4). doi: 10.1002/smll.201702700. Epub 2017 Dec 1.

Biodegradable Nanoagents with Short Biological Half-Life for SPECT/PAI/MRI Multimodality Imaging and PTT Therapy of Tumors.

Chen L1,2, Chen J3, Qiu S1,2, Wen L1,2, Wu Y1,2, Hou Y4, Wang Y1,2, Zeng J1,2, Feng Y1,2, Li Z1,2, Shan H3,5, Gao M1,2,4,6.

Author information

1
Center for Molecular Imaging and Nuclear Medicine, School for Radiological and Interdisciplinary Sciences (RAD-X), Soochow University, Suzhou, 215123, China.
2
Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou, 215123, China.
3
Department of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, China.
4
Institute of Chemistry, Chinese Academy of Sciences, Beijing, 100190, China.
5
Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, 519000, P. R. China.
6
School of Chemistry and Chemical Engineering, University of Chinese Academy of Sciences, Beijing, 100049, P. R. China.

Abstract

Rapid clearance of nanoagents is a critical criterion for their clinical translation. Herein, it is reported that biodegradable and renal clearable nanoparticles are potentially useful for image-guided photothermal therapy of tumors. The multifunctional nanoparticles with excellent colloidal stability are synthesized through coordination reactions between Fe3+ ions and gallic acid (GA)/polyvinyl pyrrolidone (PVP) in aqueous solution. Detailed characterization reveals that the resulting Fe3+ /GA/PVP complex nanoparticles (FGPNs) integrate strong near-infrared absorption with paramagnetism well. As a result, the FGPNs present outstanding performance for photoacoustic imaging and magnetic resonance imaging of tumors, and outstanding photothermal ablation effect for tumor therapy owing to their high photothermal conversion efficiency. More importantly, the pharmacokinetic behaviors of the FGPNs determined through 125 I labeling suggest that the FGPNs are readily degraded in vivo showing a short biological half-life, and the decomposition products are excreted through either renal clearance pathway or bowel elimination pathway via stomach, which highlights the characteristics of the current multifunctional theranostic agent and their potential in clinical translation.

KEYWORDS:

coordination polymer nanoparticles; multimodality imaging; pharmacokinetics; radiolabeling; theranostic agents

PMID:
29194958
DOI:
10.1002/smll.201702700

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center